Enable JavaScript to visit this website.

Activate

THE GLOBAL BREAST CANCER COMMUNITY

See the realities faced by patients with metastatic breast cancer (mBC) around the world and view some local initiatives to drive awareness and fight this disease.

APAC Region

APAC Region

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

THROUGH MY EYES

The awareness of metastatic breast cancer (mBC) is significantly low across the Asia Pacific (APAC) region. Through My Eyes is an initiative to address the low awareness and understanding of mBC in the APAC community. At the heart of the initiative are the stories of women living with mBC and their support network in APAC, as well as healthcare professionals who have dedicated their professional life to improving care of mBC patients. This forum provides a platform to share their journey and offer hope and support for other women living with mBC.

Learn More About Through My Eyes

Learn More
Argentina

Argentina

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

PALABRA DE MUJER

Pfizer joined efforts with 4 NGOs to bring Palabra de Mujer (Woman’s Voice) to life. Palabra de Mujer is a dictionary built with the valuable contribution of 11 patients with metastatic breast cancer. These women’s experiences inevitably led them to look at life differently, and they have channeled their transformative wisdom into inspirational lessons that invite us all to reflect and appreciate life differently.

Find out more about Palabra de Mujer

Learn More
Australia

Australia

Who We’re Fighting For:

Belinda

Meet Belinda, a 40-year-old woman with mBC living in Sydney, Australia. Hear her talk about her diagnosis and how she cofounded a mBC support group.

Belinda’s Challenges
Belinda’s Support System
Belinda’s Diagnosis Story

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

France

France

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

SEINCHRONE

SEINCHRONE is an initiative to champion for everyone affected by metastatic breast cancer (mBC). Through collaboration, we believe we can improve the lives of those living with metastatic breast cancer, optimize coordinated care, and provide a forum of support and encouragement for all.

Find out more about the SEINCHRONE initiative

Learn More
United Kingdom

United Kingdom

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

BREAST CANCER NOW’S

CATALYST PROGRAMME

Pfizer has committed £10 million (USD $15M) over 3 years to fund research proposed by the Breast Cancer Now Catalyst Programme. The Programme allows the scientific community to propose research projects based on their insights into patient needs and understanding of cancer therapies, bringing together industry, researchers, and funders to advance the development of breast cancer treatments.

Find out about Breast Cancer Now’s Catalyst Programme

Learn More
Models used for illustrative purposes

BREAST CANCER NOW’S CATALYST PROGRAMME

Pfizer has committed £10 million (USD $15M) over 3 years to fund research proposed by the Breast Cancer Now Catalyst Programme. The Programme allows the scientific community to propose research projects based on their insights into patient needs and understanding of cancer therapies, bringing together industry, researchers, and funders to advance the development of breast cancer treatments.

Find out about Breast Cancer Now’s Catalyst Programme

Learn More
Turkey

Turkey

Who We’re Fighting For:

YELIZ

Yeliz is a 40-year-old woman living with mBC in Istanbul, Turkey. Hear her talk about bringing awareness to the global mBC landscape from diagnosis to treatment for all those impacted.

Yeliz’s Challenges
Yeliz’s Diagnosis Story
Yeliz’s Support System

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

Spain

Spain

Who We’re Fighting For:

Amelia

Meet Amelia, a 51-year-old woman with mBC living in Aragón, Spain. Hear her talk about her diagnosis and how her friends and family helped support her throughout the process.

Amelia’s Challenges
Amelia’s Support System
Amelia’s Diagnosis Story

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

European Region

European Region

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

ME & METASTATIC BREAST CANCER

Some adults are fighting metastatic breast cancer (mBC). Others have loved ones with a new diagnosis. No matter their relationship with the disease, Me & mBC aims to help all those affected by offering solutions that are right for them. Our hope is that this site encourages all visitors to make the most of every day.

Find out more about Me & mBC

Learn More

BREAST CANCER MATTERS

Breast Cancer Matters brings together the voices and stories of those working every day to improve the lives of women living with breast cancer (BC) and metastatic breast cancer (mBC). Physicians, patients, advocates, researchers, organizations, institutions, and decision makers provide their personal perspectives on BC and mBC and where improvements are needed.

Find out more about Breast Cancer Matters

Learn More

EMOTIONSPACE

Pfizer developed the EmotionSpace app, which enables women with metastatic breast cancer (mBC) to express emotions without judgment and ask for support if and when needed. The app was co‐created together with a group comprised of breast cancer patients and patient advocates to support women living with mBC in their daily lives.

The EmotionSpace app is available in select countries, as well as in the EU and beyond. EmotionSpace allows users to:

  • Record and document their emotions
  • Communicate their feelings to friends or family and ask for support when needed
  • Generate a ʺfeelings curveʺ over time to share with their HCPs
  • Search for nearby advocacy meetings and patient services

Find out more about EmotionSpace and download the app

Learn More

THE WHITE PAPER ON CANCER CARERS

This collaboration between the European Cancer Coalition and Eurocarers challenges specific policy and calls for legislative change. It's an action plan for elevating the quality of life of the unsung carers.

Access the White Paper on Cancer Carers

Learn More

THE 2017 mBC SUMMIT

Across borders and professions, the mBC Summit convenes to address the shortcomings in policy and care and to celebrate the achievements in the fight against metastatic breast cancer. By sharing knowledge and experience we improve the lives of women with mBC, because every day is precious.

View the 2017 mBC Summit Report

mBC: COMMUNICATION AND CARE

The Consensus Recommendations on Communication between Healthcare Professionals and Patients: Prepare – Ask – Listen – Motivate (PALiMo) was a key output from the 2nd mBC Summit. The recommendations are a concord between 52 participants, including patients and key treatment team members from across the globe. The objective was to provide concrete and practical recommendations for possible inclusion in existing medical and scientific guidelines.

View the PALiMo Recommendations

United States

United States

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

A STORY HALF TOLD

A Story Half Told is an initiative by Pfizer in partnership with advocates, patients and healthcare professionals that aims to elevate public understanding of metastatic breast cancer, dispel misperceptions, combat stigma and expand the breast cancer conversation to be more inclusive of metastatic breast cancer.

Find out about A Story Half Told

Learn More

ADVANCING SCIENCE THROUGH PFIZER-INVESTIGATOR RESEARCH EXCHANGE (ASPIRE)

The ASPIRE program underscores Pfizer’s commitment to supporting investigators in advancing their academic research in advanced breast cancer and other therapeutic areas.

Find out about the ASPIRE program

Learn More

AVON-PFIZER METASTATIC BREAST CANCER GRANTS PROGRAM

Since 2014, Pfizer and the Avon Breast Cancer Crusade have partnered to establish the Avon-Pfizer Metastatic Breast Cancer Grants Program to address the gaps in support available to women and men living with mBC.

Find out more about Avon-Pfizer Metastatic Breast Cancer Grants Program

Learn More

BREAST CANCER RESEARCH FOUNDATION’S (BCRF) DRUG RESEARCH COLLABORATIVE

BCRF has received a 3-year, $15 million grant from Pfizer, along with access to all of Pfizer’s marketed and pipeline assets, to support its Drug Research Collaborative. The collaborative offers a new model for bridging the gap between academic investigators and the industry partners who can provide access to developmental oncology drugs.

The program will initially support 6 laboratory studies and 3 clinical trials that will collectively benefit nearly 400 patients with metastatic disease. The clinical studies will be conducted and managed by the Translational Breast Cancer Research Consortium (TBCRC).

Find out about BCRF’s Drug
Research Collaborative

Learn More
Mexico

Mexico

Who We’re Fighting For:

Esther

Meet Esther, a 33-year-old woman with mBC living in Mexico City, Mexico. Hear her talk about her diagnosis and the strength she found in a support system.

Esther’s Challenges
Esther’s Support System
Esther’s Diagnosis Story

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

Brazil

Brazil

Who We’re Fighting For:

Elfriede

Meet Elfriede, a 61-year-old woman from Saõ Paolo, Brazil. Hear her mBC story from diagnosis to treatment, and her support along the way.

Elfriede’s Challenges & Triumphs
Elfriede’s Support System
Elfriede’s Treatment Journey

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

GLOBAL INITIATIVE

SPARC Mbc challenge

The Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge (SPARC MBC Challenge) is an initiative of the Union for International Cancer Control (UICC) supported by Pfizer that aims to empower advocacy groups, hospital networks, support groups, and other organizations worldwide as they initiate projects to address the specific needs of women living with metastatic breast cancer.

Grants are awarded for projects focused on closing the gap in information, support, awareness, and policy between metastatic breast cancer and early breast cancer, as well as helping reduce the number of women first diagnosed at the metastatic stage of the disease.

Find out more about the SPARC MBC Challenge and the UICC

Learn More